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Abstract
Yucca schidigera is a medicinal plant native to Mexico. According to folk medicine, yucca extracts
have anti-arthritic and anti-inflammatory effects. The plant contains several physiologically active
phytochemicals. It is a rich source of steroidal saponins, and is used commercially as a saponin
source. Saponins have diverse biological effects, including anti-protozoal activity. It has been
postulated that saponins may have anti-arthritic properties by suppressing intestinal protozoa
which may have a role in joint inflammation. Yucca is also a rich source of polyphenolics, including
resveratrol and a number of other stilbenes (yuccaols A, B, C, D and E). These phenolics have anti-
inflammatory activity. They are inhibitors of the nuclear transcription factor NFkappaB. NFkB
stimulates synthesis of inducible nitric oxide synthase (iNOS), which causes formation of the
inflammatory agent nitric oxide. Yucca phenolics are also anti-oxidants and free-radical scavengers,
which may aid in suppressing reactive oxygen species that stimulate inflammatory responses. Based
on these findings, further studies on the anti-arthritic effects of Yucca schidigera are warranted.
Introduction
Yucca schidigera is an herbaceous plant of the lily family,
native to the deserts of the south-western United States
and northern Mexico. This plant was used in traditional
medicine by Native Americans to treat a variety of ail-
ments including arthritis. Yucca products are currently
used in a number of applications. Yucca powder and
yucca extract are used as animal feed additives, as dis-
cussed in detail by Cheeke and Otero [1]. Beneficial effects
in livestock and poultry production include: increased
growth rate and improved feed conversion efficiency,
reduction in atmospheric ammonia in confinement ani-
mal and poultry facilities, anti-protozoal and nematocidal
activity, modification of ruminal microbe populations,
inhibition of Gram-positive bacteria, reductions in still-
births in swine, reduction in egg and tissue cholesterol
contents, and anti-arthritic activity in horses and dogs.
Other applications include the use of yucca extract as a
foaming agent in beverages, and use in crop production as
nematode and fungi-control agents, as a soil wetting
agent, and crop growth stimulant. Yucca products have
GRAS status, so are FDA-approved for use in humans.
Yucca saponins
Yucca contains a number of phytochemicals which con-
tribute to these effects. The best known are the steroidal
saponins. Saponins are natural detergents [2] that form
stable foams. Saponins contain a lipophilic nucleus (the
sapogenin) and one or more side chains of hydrophilic
carbohydrate (Fig. 1). Thus the intact saponin molecule is
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a surfactant, with both fat-soluble and water-soluble
moities. It has been known for many years [3] that sapon-
ins form insoluble complexes with cholesterol. The
hydrophobic portion of the saponin (the aglycone or
sapongenin) associates (lipophilic bonding) with the
hydrophobic sterol nucleus of cholesterol in a stacked
micellar aggregation [4].
Interactions of saponins with cholesterol and other sterols
account for many of their biological effects, particularly
those involving membrane activity. It was demonstrated
more than 45 years ago that dietary saponin reduces
blood cholesterol levels [5,6]. This effect is a result of the
saponins binding to cholesterol excreted in bile, thus
inhibiting entero-hepatic cholesterol recycling. Dietary
yucca extracts lower total and LDL cholesterol levels in
hypercholesterolemic humans [7]. Saponins affect the
permeability of intestinal cells by forming complexes with
cholesterol in mucosal cell membranes [8]. In a similar
manner, saponins have anti-protozoal activity by com-
plexing with cholesterol in protozoal cell membranes,
causing damage to the integrity of the membrane, and cell
lysis. This has been well demonstrated with rumen proto-
zoa in vivo [9-11]; and in vitro [12,13]. The antiprotozoal
(cholesterol-binding) activity requires the intact saponin
structure with both nucleus and side chain present.
Protozoal diseases in which part of the life cycle occurs in
the gastrointestinal tract respond to the anti-protozoal
activity of saponins. For example, yucca saponins are as
effective as the drug metronidazole in killing tropozoites
of Giardia lamblia in the intestine [14]. Yucca schidigera
contains as much as 10% of steroidal saponins in its stem
dry matter, making this plant one of the richest commer-
cial sources of saponins. Acid hydrolysed fractions of
yucca contain both furostanol and spirostanol aglycones.
These include sarsapogenin, markogenin, smilagenin,
samogenin, gitogenin and neogitogenin [15]. In the plant
they can be found in a multi-component mixture of glyco-
sides [16,17]. They can be found both as monodesmo-
sides with one sugar chain attached at 3-O- and
bidesmosides with two sugar chains at 3-O- and 26-O-
positions (Fig. 1). Tanaka and co-workers identified as
many as 13 structurally different saponins, but all of them
were monodesmosides, given trivial names YS-I-XIII [16].
In the work of Oleszek and co-workers, eight individual
saponins were isolated and identified out of which five
were known spirostanol and three new furostanol struc-
tures [17]. However, monodesmosides made up about
93% of total saponins present.
Yucca phenolics
Recently it has been recognized that yucca contains other
physiologically-active constituents, particularly polyphe-
nols. Two stilbenes, including trans-3,3',5,5'-tetrahy-
Chemical structures of saponins identified in Yucca schidigera  bark [17] Figure 1
Chemical structures of saponins identified in Yucca schidigera 
bark [17]. Compounds 1–4 represent monodesmosidic and 
6–7 bidesmosidic structures.
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Structures of yucca phenolics Figure 2
Structures of yucca phenolics.
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droxy-4'-methoxystilbene and trans-3,4',5-
tetraxydroxystilbene (resveratrol) were identified in yucca
bark. Also, some unique compounds with spiro confirma-
tion were isolated and characterized. These included the
spirobiflavonoid, larixinol, biosynthesized by combining
two C15 units of flavonoid origin, previously identified in
Larix gmelini and a number of novel spirostructures, which
were given trivial names of yuccaols A-E [18,19] (Fig. 2).
These compounds are composed of a C15 unit probably
originating from the flavonoid skeleton and a C14 stilbe-
nic compound linked via γ-lactone ring. Resveratrol
makes up the stilbenic portion of yuccaols A and B and
trans-3,3',5,5'-tetrahydroxy-4'-methoxystilbene is the stil-
bene in yuccaols C, D and E. By the analogy to the biosyn-
thesis of larixinol it was presumed that most probably
these compounds are synthesized by the attachment of
the stilbenic derivative to the carbocationic intermediate
occurring during the oxidation of flavanone to flavanol
and subsequent rearrangement of this intermediate. Res-
veratrol was identified previously in grapes and is believed
to be a phytoalexin produced by the plant to fight fungal
colonization [20]. In yucca, this compound as well as its
methoxyderivative and yuccaols can be found exclusively
in yucca bark (Table 1), which is a dead tissue; it is not
clear how these compounds are accumulated in this plant
organ. Since yucca bark is a component of commercially
available yucca powder, these compounds are present
exclusively in this product; they are not present in yucca
extract obtained by mechanical extraction.
The chemistry and bioactivity of yucca saponins and phe-
nolics have recently been reviewed by Piacente et al. [21].
Anti-arthritic effects of yucca
Yucca products have been used for many years for reputed
anti-arthritic effects, both by Native Americans and more
recently by the nutraceutical industry. Whole yucca plant
powder in tablet form is a common nutraceutical. The
only direct studies of anti-arthritic effects of yucca are
those of Bingham [22-24], who reported that symptoms
of pain and swelling in arthritic human patients were
relieved by consumption of yucca tablets. Bingham's work
was reported in an obscure journal, and has apparently
not been recognized as valid by the arthritis research com-
munity. Nevertheless, Bingham's reports have led to the
widespread use of yucca products for treatment and pre-
vention of arthritis not only in humans but also in horses
and dogs.
Bingham [22] proposed that yucca saponins have anti-
protozoal activity, which suppresses protozoal infection
of the intestine. Bingham [22] reported that R. Wyburn-
Mason had observed a free-living protozoan, Naegleria,
universally present in the joints of arthritic patients [25].
Tropozoites of the organism reportedly were found in the
intestine. Support for this theory was provided by the
effectiveness of metronidazole, an anti-protozoal drug, in
arthritis treatment. Saponins are also effective anti-proto-
zoal agents. Yucca saponins are as effective as metronida-
zole in killing giardia tropozoites in the intestine [14].
Thus, if the protozoal theory of causation of arthritis has
any merit, a role of yucca in arthritis treatment can be
advanced on the basis of the anti-protozoal activity of
yucca saponins.
Representative blot of iNOS expression (a). Densitometric  analysis of concentration-dependent effect of Yuccaol C  (0.01–100 µM) on LPS-induced iNOS expression in J774.A1  macrophages Figure 3
Representative blot of iNOS expression (a). Densitometric 
analysis of concentration-dependent effect of Yuccaol C 
(0.01–100 µM) on LPS-induced iNOS expression in J774.A1 
macrophages (b). Yuccaol C was added 1 h before and simul-
taneously with LPS challenge. Values, mean ± s.e.m., are 
expressed as %inhibition of at least 6–9 independent experi-
ments with 3 replicates each. Comparisons were made using 
one way ANOVA test. *P < 0.05, and **P < 0.01 [34]
Table 1: Concentrations of phenolics in different fractions of yucca [28].
Item Resveratrol (mg/g) Yuccaols (mg/g)
Yucca bark 21.7 72.6
Yucca whole plant powder 3.2 10.0
Yucca extract NP* NP
*NP = not present.Journal of Inflammation 2006, 3:6 http://www.journal-inflammation.com/content/3/1/6
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There are well-known interactions between rheumatoid
arthritis, chronic inflammatory disease, and food and
nutrition [26,27]. Of particular importance are nutrients
that stimulate the formation of oxidants and peroxides
(e.g. unsaturated fatty acids, iron), which promote inflam-
matory disease, and antioxidants (e.g. vitamin E) and
omega-3 fatty acids, which protect against auto-oxidation.
Yucca compounds may have roles in these effects. Yucca
polyphenols are potent antioxidants [18,21,28]. Yucca
saponins are known to reduce iron absorption [29] and
may reduce fatty acid absorption by sequestering bile
acids necessary for micelle formation and fat absorption
[4].
Cordain [30] stated, "Despite the almost universal clinical
observation that inflammation of the gut is frequently
associated with inflammation of the joints and vice-versa,
the nature of the relationship remains elusive." These
authors reported that arthritis is associated with intestinal
bacterial overgrowth of Escherichia coli and Lactobacillus
lactis. Yucca saponins have antibacterial properties
[31,32], although Lactobacillus spp. and E. coli may be tol-
Effect of yuccaol C (0.01–100 µM) on NF-kB in LPS-stimulated J774.A1 macrophages Figure 4
Effect of yuccaol C (0.01–100 µM) on NF-kB in LPS-stimulated J774.A1 macrophages. Values, mean ± s.e.m., are expressed as 
optical density/mm2 of at least 3 independent experiments with 3 replicates each. Comparisons were performed using one way 
ANOVA test. *P < 0.05, and **P < 0.01 [34]Journal of Inflammation 2006, 3:6 http://www.journal-inflammation.com/content/3/1/6
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erant of yucca extract and yucca saponins [31]. Thus, a
beneficial effect of yucca on arthritis could involve anti-
protozoal, anti-oxidant and anti-bacterial activities. As
previously mentioned, the drug metronidazole attenuates
gastrointestinal inflammation and can prevent activation
of arthritis in animal models [30]. Yucca saponins are as
effective as metronidazole in control of intestinal proto-
zoa [14].
Recent research suggests another possible mode of action
of yucca in preventing arthritis by anti-inflammatory
activity. Yucca contains anti-inflammatory polyphenolics
such as resveratrol and yuccaols A, B, C, D and E [18,19].
Yucca bark and whole yucca plant powder contain resver-
atrol (Table 1), well known for its anti-inflammatory
activity [20,33]. Marzocco [34] demonstrated that yuc-
caols inhibit inducible nitric oxide synthase (iNOS)
expression (Fig. 3). Nitric oxide is an inflammatory agent,
and its content in tissues increases during inflammatory
responses. The expression of iNOS is controlled by NFka-
ppaB (NFkB), a transcription factor that regulates gene
expression. Resveratrol and yucca phenolics strongly
inhibit NFkB [34]. Yuccaol C is particularly effective (Fig.
3 and 4). Thus, whole plant yucca powder has powerful
anti-inflammatory activity, mediated via inhibition of
NFkB activation.
The generation of reactive oxygen species (free radicals) is
an important factor in the development and maintenance
of rheumatoid arthritis in humans and animal models
[35]. One source of free radicals is nitric oxide produced
within the synoviocytes and chondrocytes, giving rise to
the highly toxic radical peroxynitrite [35]. The study of
experimental arthritis in animals has demonstrated an
increased activity of iNOS [36,37]. Thus the NFkB inhibi-
tory and anti-oxidant effects of yucca polyphenolics may
aid in prevention of reactive oxygen species (ROS) induc-
tion of arthritis by inhibiting the induction of iNOS.
Platelet aggregation is characteristic of inflammation.
Yucca phenolics have inhibitory activity against platelet
aggregation [38-40]. Yucca phenolics also have antioxi-
dant activity [19] and free-radical scavenging effects [18].
Blood platelets participate in allergic inflammation
responses [41]. Yuccaols inhibit the generation of free rad-
icals in blood platelets [39]. One of the yucca phenolics,
trans-3,3',5,5'-tetrahydroxy-4-methoxystilbene, showed
the highest anti-platelet action.
Another botanical product with anti-inflammatory activ-
ity is cat's claw [42]. As reviewed by Miller et al. [42], cat's
claw (Uncaria guianensis) "is a remarkably potent inhibi-
tor of NFkB activity and tumor necrosis factor produc-
tion." Evaluation of the anti-inflammatory activity of a
combination of yucca and cat's claw would be of interest.
The evidence presented in this review indicates that yucca
has potential in vivo anti-inflammatory activity, and war-
rants more in-depth investigation.
Conclusion
Yucca schidigera is a medicinal plant which may have ben-
eficial effects in the prevention and treatment of arthritis.
Active components of yucca include steroidal saponins
and polyphenolics such as resveratrol and yuccaols.
Saponins may have anti-arthritic effects associated with
their anti-protozoal activity. Yucca polyphenolics may
have several roles in anti-arthritic activity. They inhibit
NFkB, a transcription factor which stimulates iNOS, an
inducible enzyme which produces the inflammatory
agent nitric oxide. Yucca phenolics also are antioxidants
and free-radical scavengers, which may aid in suppressing
reactive oxygen species (ROS) that stimulate inflamma-
tory responses. Folk medicine and anecdotal reports sug-
gest that whole yucca plant powder aids in prevention and
treatment of arthritis. Further studies on the anti-arthritic
effects of yucca are warranted.
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